Literature DB >> 12502689

Is metformin cardioprotective?

Afshin Sasali, Jack L Leahy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12502689     DOI： 10.2337/diacare.26.1.243

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Comment on: Evans JM, Ogston SA, Emslie-Smith A, Morris A (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.

Authors:  J A Johnson; S H Simpson; D T Eurich; S R Majumdar
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

2.  Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.

Authors:  Scot H Simpson; Sumit R Majumdar; Ross T Tsuyuki; Dean T Eurich; Jeffrey A Johnson
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

3.  Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin.

Authors:  J M M Evans; S A Ogston; A Emslie-Smith; A D Morris
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122

4.  Metformin and its clinical use: new insights for an old drug in clinical practice.

Authors:  Arrigo F G Cicero; Elisa Tartagni; Sibel Ertek
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.